{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:27:24Z","timestamp":1761744444423,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003491","name":"Herlev Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-016-0437-6","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T23:14:01Z","timestamp":1484003641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve"],"prefix":"10.1186","volume":"17","author":[{"given":"Pernille","family":"Holmager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Egstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi S.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Melholt","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob E.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Tuxen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Kistorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"437_CR1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2003.11.024","volume":"43","author":"I Gustafsson","year":"2004","unstructured":"Gustafsson I, Brendorp B, Seibaek M, et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol. 2004;43:771\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"437_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurjhf\/hfq216","volume":"13","author":"M Egstrup","year":"2011","unstructured":"Egstrup M, Schou M, Gustafsson I, et al. Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis. Eur J Heart Fail. 2011;13(3):319\u201326.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"437_CR3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ehjci\/jes165","volume":"14","author":"M Egstrup","year":"2013","unstructured":"Egstrup M, Kistorp CN, Schou M, et al. Abnormal glucose metabolism is associated with reduced left ventricular contractile reserve and exercise intolerance in patients with chronic heart failure. Eur Heart J Cardiovasc Imaging. 2013;14(4):349\u201357.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"437_CR4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0735-1097(95)00393-2","volume":"27","author":"MJ Williams","year":"1996","unstructured":"Williams MJ, Odabashian J, Lauer MS, et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 1996;27(1):132\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"437_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejheart.2004.01.017","volume":"7","author":"P Otasevic","year":"2005","unstructured":"Otasevic P, Popovic ZB, Vasiljevic JD, et al. Relation of myocardial histomorphometric features and left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2005;7(1):49\u201356.","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"437_CR6","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel TJ, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004;110(19):3121\u20138.","journal-title":"Circulation"},{"issue":"11","key":"437_CR7","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3760\/cmaj.issn.0366-6999.20130217","volume":"126","author":"QH Jin","year":"2013","unstructured":"Jin QH, Lou YF, Li TL, et al. Serum galectin-3: a risk factor for vascular complications in type 2 diabetes mellitus. Chin Med J (Engl). 2013;126(11):2109\u201315.","journal-title":"Chin Med J (Engl)"},{"key":"437_CR8","doi-asserted-by":"publisher","unstructured":"Gopal DM, Kommineni M, Ayalon N et al. Relationship of plasma galectin-3 to renal fuinction in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or abscence of heart failure. J Am Heart Assoc. 2012;1(5):e000760. doi: 10.1161\/JAHA.112.000760 . Epub 2012 Oct 25.","DOI":"10.1161\/JAHA.112.000760"},{"key":"437_CR9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejheart.2006.05.004","volume":"8","author":"V Beisvag","year":"2006","unstructured":"Beisvag V, Lehre PK, Midelfart H, et al. Aetiology-sepcific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data. Eur J Heart Fail. 2006;8:381\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"437_CR10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000354217","volume":"126","author":"ML Hansen","year":"2013","unstructured":"Hansen ML, Dahl JS, Argraves WS, et al. Aortic valve stenosis and atrial fibrillation influence plasma fibulin-1 levels in patients treated with coronary bypass surgery. Cardiology. 2013;126(3):202\u20136.","journal-title":"Cardiology"},{"key":"437_CR11","doi-asserted-by":"publisher","unstructured":"Schoze A, Bladbjerg EM, Sidelmann Jj et al. Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovascl. Diabetol 2013 Jan 7;12:6. Doi: 10.1186\/1475-2840-12-6","DOI":"10.1186\/1475-2840-12-6"},{"issue":"6","key":"437_CR12","doi-asserted-by":"crossref","first-page":"e003889","DOI":"10.1161\/JAHA.112.003889","volume":"1","author":"JS Dahl","year":"2012","unstructured":"Dahl JS, Moller JE, Videbaek L, et al. Plasma fibulin-1 is linked to restrictive filling of the left ventricle and to mortality in patients with aortic valve stenosis. J Am Heart Assoc. 2012;1(6):e003889.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"437_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","volume":"7","author":"RM Lang","year":"2006","unstructured":"Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79\u2013108.","journal-title":"Eur J Echocardiogr"},{"issue":"7\u20138","key":"437_CR14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinbiochem.2010.02.001","volume":"43","author":"RH Christenson","year":"2010","unstructured":"Christenson RH, Duh SH, Wu AH, et al. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. Clin Biochem. 2010;43(7\u20138):683\u201390.","journal-title":"Clin Biochem"},{"issue":"11","key":"437_CR15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1373\/clinchem.2011.162966","volume":"57","author":"C Cangemi","year":"2011","unstructured":"Cangemi C, Skov V, Poulsen MK, et al. Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem. 2011;57(11):1556\u201365.","journal-title":"Clin Chem"},{"issue":"6 Pt 2","key":"437_CR16","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1083\/jcb.111.6.3155","volume":"111","author":"WS Argraves","year":"1990","unstructured":"Argraves WS, Tran H, Burgess WH, et al. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol. 1990;111(6 Pt 2):3155\u201364.","journal-title":"J Cell Biol"},{"issue":"3","key":"437_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amjcard.2011.03.056","volume":"108","author":"WH Tang","year":"2011","unstructured":"Tang WH, Shrestha K, Shao Z, et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am J Cardiol. 2011;108(3):385\u201390.","journal-title":"Am J Cardiol"},{"issue":"3","key":"437_CR18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","volume":"95","author":"J Weigert","year":"2010","unstructured":"Weigert J, Neumeier M, Wanninger J, et al. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocrinol Metab. 2010;95(3):1404\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"437_CR19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2337\/dc13-1022","volume":"37","author":"V Skov","year":"2014","unstructured":"Skov V, Cangemi C, Gram J, et al. Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes. Diabetes Care. 2014;37(3):760\u20136.","journal-title":"Diabetes Care"},{"issue":"3","key":"437_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jdiacomp.2015.01.003","volume":"29","author":"ML Hansen","year":"2015","unstructured":"Hansen ML, Rasmussen LM. Associations between plasma fibulin-1, pulse wave velocity and diabetes in patients with coronary heart disease. J Diabetes Complications. 2015;29(3):362\u20136. doi: 10.1016\/j.jdiacomp.2015.01.003 . Epub 2015 Jan 13.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"437_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejvs.2015.09.004","volume":"51","author":"K Paapstel","year":"2016","unstructured":"Paapstel K, Zilmer M, Eha J, et al. Association between fibulin-1 and aortic augmentation index in male patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51(1):76\u201382. doi: 10.1016\/j.ejvs.2015.09.004 . Epub 2015 Oct 21.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"437_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2840-11-15","volume":"11","author":"V Skov","year":"2012","unstructured":"Skov V, Knudsen S, Olesen M, et al. Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes. Cardiovasc Diabetol. 2012;11:15.","journal-title":"Cardiovasc Diabetol"},{"issue":"14","key":"437_CR23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","volume":"60","author":"JE Ho","year":"2012","unstructured":"Ho JE, Liu C, Lyass A, et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol. 2012;60(14):1249\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"437_CR24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","volume":"57","author":"N Mewton","year":"2011","unstructured":"Mewton N, Liu CY, Croisille P, et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57(8):891\u2013903.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"437_CR25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","volume":"54","author":"TD Karamitsos","year":"2009","unstructured":"Karamitsos TD, Francis JM, Myerson S, et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54(15):1407\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"437_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1159\/000445103","volume":"134","author":"EG Singsaas","year":"2016","unstructured":"Singsaas EG, Manhenke CA, Dickstein K, et al. Circulation Galectin-3 levels are increased in patients with ischemic heart disease, but are not influenced by acute myocardial infarction. Cardiology. 2016;134:398\u2013405. doi: 10.1159\/000445103 .","journal-title":"Cardiology"},{"issue":"8","key":"437_CR27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","volume":"12","author":"RV Shah","year":"2010","unstructured":"Shah RV, Chen-Tournoux AA, Picard MH, et al. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail. 2010;12(8):826\u201332.","journal-title":"Eur J Heart Fail"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0437-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T18:00:05Z","timestamp":1718992805000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0437-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0437-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2017,1,10]]},"article-number":"22"}}